The Cooper Companies, Inc. $COO Shares Sold by Farther Finance Advisors LLC

Farther Finance Advisors LLC cut its position in The Cooper Companies, Inc. (NASDAQ:COO) by 42.4% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,263 shares of the medical device company’s stock after selling 929 shares during the quarter. Farther Finance Advisors LLC’s holdings in Cooper Companies were worth $90,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also modified their holdings of the company. UMB Bank n.a. grew its stake in shares of Cooper Companies by 16.7% in the first quarter. UMB Bank n.a. now owns 902 shares of the medical device company’s stock valued at $76,000 after buying an additional 129 shares in the last quarter. Horizon Investments LLC grew its stake in Cooper Companies by 5.0% during the 1st quarter. Horizon Investments LLC now owns 2,859 shares of the medical device company’s stock worth $241,000 after purchasing an additional 136 shares in the last quarter. Axxcess Wealth Management LLC grew its stake in Cooper Companies by 1.9% during the 1st quarter. Axxcess Wealth Management LLC now owns 7,382 shares of the medical device company’s stock worth $623,000 after purchasing an additional 140 shares in the last quarter. Exchange Traded Concepts LLC grew its stake in Cooper Companies by 16.3% during the 1st quarter. Exchange Traded Concepts LLC now owns 1,502 shares of the medical device company’s stock worth $127,000 after purchasing an additional 210 shares in the last quarter. Finally, Wealth Alliance LLC grew its stake in Cooper Companies by 5.5% during the 1st quarter. Wealth Alliance LLC now owns 4,059 shares of the medical device company’s stock worth $342,000 after purchasing an additional 210 shares in the last quarter. 24.39% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, Director Lawrence Erik Kurzius bought 2,000 shares of Cooper Companies stock in a transaction dated Monday, September 29th. The stock was acquired at an average cost of $68.39 per share, with a total value of $136,780.00. Following the acquisition, the director owned 5,777 shares of the company’s stock, valued at approximately $395,089.03. This trade represents a 52.95% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Albert G. White III bought 10,000 shares of Cooper Companies stock in a transaction dated Friday, September 5th. The stock was purchased at an average cost of $68.39 per share, with a total value of $683,900.00. Following the completion of the acquisition, the chief executive officer directly owned 226,151 shares in the company, valued at approximately $15,466,466.89. The trade was a 4.63% increase in their position. The disclosure for this purchase can be found here. In the last three months, insiders bought 17,975 shares of company stock worth $1,216,346. Corporate insiders own 1.98% of the company’s stock.

Cooper Companies Stock Up 1.9%

Shares of NASDAQ COO opened at $70.46 on Friday. The company has a market capitalization of $14.01 billion, a price-to-earnings ratio of 34.71, a price-to-earnings-growth ratio of 1.85 and a beta of 1.02. The company has a debt-to-equity ratio of 0.29, a current ratio of 2.12 and a quick ratio of 1.24. The business has a 50-day moving average of $69.69 and a two-hundred day moving average of $74.12. The Cooper Companies, Inc. has a 1 year low of $61.78 and a 1 year high of $109.37.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Wednesday, August 27th. The medical device company reported $1.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.07 by $0.03. The company had revenue of $1.06 billion during the quarter, compared to the consensus estimate of $1.06 billion. Cooper Companies had a return on equity of 9.82% and a net margin of 10.08%.Cooper Companies’s revenue for the quarter was up 5.7% on a year-over-year basis. During the same period in the previous year, the business earned $0.96 EPS. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. On average, analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies announced that its board has authorized a stock buyback plan on Wednesday, September 17th that permits the company to repurchase $2.00 billion in shares. This repurchase authorization permits the medical device company to repurchase up to 15.4% of its shares through open market purchases. Shares repurchase plans are often a sign that the company’s board believes its shares are undervalued.

Wall Street Analyst Weigh In

Several research analysts recently commented on COO shares. The Goldman Sachs Group set a $64.00 target price on Cooper Companies and gave the stock a “sell” rating in a research note on Wednesday. Piper Sandler lowered their target price on Cooper Companies from $105.00 to $83.00 and set an “overweight” rating for the company in a research note on Thursday, August 28th. Needham & Company LLC reissued a “buy” rating and set a $94.00 target price on shares of Cooper Companies in a research note on Thursday, August 28th. BNP Paribas Exane raised Cooper Companies from a “neutral” rating to an “outperform” rating and set a $92.00 target price for the company in a research note on Tuesday, July 22nd. Finally, BNP Paribas raised Cooper Companies from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, July 22nd. One analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $84.75.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.